Health And Wellness Executive Decisions: NIH ODS Director, B+L Consumer Chief, Herbalife, More
Army Institute Performance Division physiologist leads NIH ODS; Ferris heads B+L consumer products; medical director For HumanN supplements; and Herbalife scores Ronaldo sponsorship extension.
You may also be interested in...
Perrigo will note regulatory approval for Opill as first US OTC oral contraceptive in first earnings briefing with Patrick Lockwood-Taylor at helm. Other firsts in sector will be Kenvue’s 20 July results being its first since spin-out from J&J in May and Bausch + Lomb’s first quarterly results under CEO Saunders.
In second buy in a week, B+L paying $106.5m in cash deal for products marketed by Johnson & Johnson Vision. Acquired products are Blink Tears lubricating eye drops and Blink Contacts and Blink-N-Clean lens drops.
“Multi-year plan with three phases, all with measurable, clear objectives” starts with “rewire company for optimal performance” before moving to “innovate and execute” and then to “accelerate growth,” CEO says.